The listing will allow Moderna to distribute its vaccine around the world and will enable the United Nations Children's Fund (UNICEF) and the Pan American Health Organization (PAHO) Revolving Fund to acquire and distribute it.

In other Moderna news, the company announced a supply agreement with Gavi, the Vaccine Alliance, for up to 500 million COVID-19 vaccine doses to be distributed through Gavi's COVID-19 Vaccines Global Access (COVAX).

The agreement covers 92 Gavi COVAX low- and middle-income countries. In the fourth quarter of this year, 34 million doses will be delivered; the deal includes an option for an additional 466 million doses to be delivered in 2022, Moderna said.

DNA Script, Moderna to develop on-demand vaccines, therapeutics
DNA Script and Moderna have announced a partnership to develop on-demand vaccines and therapeutics as part of the U.S. Defense Advanced Research Projects...

Sanofi to provide fill/finish services for Moderna COVID-19 vaccine
Moderna has inked a new agreement with Sanofi in order to scale up U.S. manufacturing capacity for its COVID-19 vaccine.

Moderna provides updates on mRNA vaccine platform
Moderna gave updates on its messenger RNA (mRNA) vaccines during its second annual Vaccines Day event. The company plans to continue to invest resources...

Moderna highlights 6-month antibody persistence of its COVID-19 vaccine
Antibody persistence lasted through six months following the second dose of Moderna's COVID-19 vaccine, according to a study published April 6 in the...

Moderna announces administration of pediatric COVID-19 vaccine doses
Moderna announced that the first participants have been dosed in its phase II/III study of its pediatric messenger RNA (mRNA) COVID-19 vaccine candidate,...